LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 175 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $143,000 | -13.3% | 1,177 | -24.3% | 0.06% | +3.5% |
| Q1 2017 | $165,000 | +5.8% | 1,555 | +1.0% | 0.06% | +11.8% |
| Q4 2016 | $156,000 | -3.1% | 1,540 | -2.2% | 0.05% | +2.0% |
| Q3 2016 | $161,000 | -10.6% | 1,575 | +4.3% | 0.05% | -12.3% |
| Q2 2016 | $180,000 | +1536.4% | 1,510 | +1410.0% | 0.06% | +1800.0% |
| Q1 2016 | $11,000 | +37.5% | 100 | +42.9% | 0.00% | +50.0% |
| Q4 2015 | $8,000 | +14.3% | 70 | +7.7% | 0.00% | +100.0% |
| Q2 2015 | $7,000 | -94.8% | 65 | -97.7% | 0.00% | -97.2% |
| Q3 2014 | $135,000 | – | 2,875 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |